Anti-VEGF and steroid combination therapy for diabetic macular edema
Not Applicable
- Conditions
- diabetic macular edema
- Registration Number
- JPRN-UMIN000021630
- Lead Sponsor
- Department of Ophthalmology, Mie Universivt, School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patients treated PC within 3 months before treatment. 2)Ischemic maculopathy with FA. 3)Vitreal macular traction 4)Proliferative diabetic retinopathy 5)Glaucoma 6)Optic neuropathy 7)Past history of vitreous surgery 8)Phakic eyes 9)Any history of intravitreal injection or subtenon injection. 10)Past history of cataract surgery. 11)Steroid respondar 12)Heart failure, cerebral vascular disease,hematological dissease, tumor. 13)Patients receive general steroid treatment. 14)Hheavy renal failure over stageIII. 15)GradeIII HT 16)HbA1c NGSP over 10%
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method